Office-based sclerotherapy for benign parotid lymphoepithelial cysts in the HIV-positive patient

Eric E. Berg, Charles E. Moore

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To determine the efficacy of sodium morrhuate injection therapy in the control of benign lymphoepithelial cysts of the parotid gland. Study Design: Retrospective review. Methods: The medical records of human immunodeficiency virus (HIV)-positive patients who presented to an indigent care hospital for the evaluation and management of benign lymphoepithelial cysts of the parotid gland are reviewed. Cyst laterality, aspiration and injection volumes, and noted complications were recorded. When applicable, elapsed time between recurrent interventions was recorded. Results: Medical records were available for a total of nine patients who underwent aspiration and injection of 34 cysts. Five of the nine patients required therapy for additional cyst formation an average of 11.8 months after initial intervention. There have been no known instances of facial nerve or parotid gland injury, and the only recorded postprocedure complaints were pain and mild edema. Conclusions: While multiple cysts may arise and serial intervention may be required, we believe that in association with broader clinical experience, the data presented here support aspiration and sodium morrhuate injection as a safe, minimally invasive, and efficacious technique in the treatment of benign lymphoepithelial cysts of the parotid gland in the HIV-positive population.

Original languageEnglish (US)
Pages (from-to)868-870
Number of pages3
JournalLaryngoscope
Volume119
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Sclerotherapy
Cysts
HIV
Parotid Gland
Sodium Morrhuate
Injections
Medical Records
Uncompensated Care
Facial Nerve
Edema
Therapeutics
Retrospective Studies
Pain
Wounds and Injuries
Population
Aspirations (Psychology)

Keywords

  • HIV
  • Lymphoepithelial cyst
  • Parotid gland
  • Sclerotherapy
  • Sodium morrhuate

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Cite this

Office-based sclerotherapy for benign parotid lymphoepithelial cysts in the HIV-positive patient. / Berg, Eric E.; Moore, Charles E.

In: Laryngoscope, Vol. 119, No. 5, 05.2009, p. 868-870.

Research output: Contribution to journalArticle

Berg, Eric E. ; Moore, Charles E. / Office-based sclerotherapy for benign parotid lymphoepithelial cysts in the HIV-positive patient. In: Laryngoscope. 2009 ; Vol. 119, No. 5. pp. 868-870.
@article{a38fc4913bca4a7eac3bd05480432632,
title = "Office-based sclerotherapy for benign parotid lymphoepithelial cysts in the HIV-positive patient",
abstract = "Objective: To determine the efficacy of sodium morrhuate injection therapy in the control of benign lymphoepithelial cysts of the parotid gland. Study Design: Retrospective review. Methods: The medical records of human immunodeficiency virus (HIV)-positive patients who presented to an indigent care hospital for the evaluation and management of benign lymphoepithelial cysts of the parotid gland are reviewed. Cyst laterality, aspiration and injection volumes, and noted complications were recorded. When applicable, elapsed time between recurrent interventions was recorded. Results: Medical records were available for a total of nine patients who underwent aspiration and injection of 34 cysts. Five of the nine patients required therapy for additional cyst formation an average of 11.8 months after initial intervention. There have been no known instances of facial nerve or parotid gland injury, and the only recorded postprocedure complaints were pain and mild edema. Conclusions: While multiple cysts may arise and serial intervention may be required, we believe that in association with broader clinical experience, the data presented here support aspiration and sodium morrhuate injection as a safe, minimally invasive, and efficacious technique in the treatment of benign lymphoepithelial cysts of the parotid gland in the HIV-positive population.",
keywords = "HIV, Lymphoepithelial cyst, Parotid gland, Sclerotherapy, Sodium morrhuate",
author = "Berg, {Eric E.} and Moore, {Charles E.}",
year = "2009",
month = "5",
doi = "10.1002/lary.20205",
language = "English (US)",
volume = "119",
pages = "868--870",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Office-based sclerotherapy for benign parotid lymphoepithelial cysts in the HIV-positive patient

AU - Berg, Eric E.

AU - Moore, Charles E.

PY - 2009/5

Y1 - 2009/5

N2 - Objective: To determine the efficacy of sodium morrhuate injection therapy in the control of benign lymphoepithelial cysts of the parotid gland. Study Design: Retrospective review. Methods: The medical records of human immunodeficiency virus (HIV)-positive patients who presented to an indigent care hospital for the evaluation and management of benign lymphoepithelial cysts of the parotid gland are reviewed. Cyst laterality, aspiration and injection volumes, and noted complications were recorded. When applicable, elapsed time between recurrent interventions was recorded. Results: Medical records were available for a total of nine patients who underwent aspiration and injection of 34 cysts. Five of the nine patients required therapy for additional cyst formation an average of 11.8 months after initial intervention. There have been no known instances of facial nerve or parotid gland injury, and the only recorded postprocedure complaints were pain and mild edema. Conclusions: While multiple cysts may arise and serial intervention may be required, we believe that in association with broader clinical experience, the data presented here support aspiration and sodium morrhuate injection as a safe, minimally invasive, and efficacious technique in the treatment of benign lymphoepithelial cysts of the parotid gland in the HIV-positive population.

AB - Objective: To determine the efficacy of sodium morrhuate injection therapy in the control of benign lymphoepithelial cysts of the parotid gland. Study Design: Retrospective review. Methods: The medical records of human immunodeficiency virus (HIV)-positive patients who presented to an indigent care hospital for the evaluation and management of benign lymphoepithelial cysts of the parotid gland are reviewed. Cyst laterality, aspiration and injection volumes, and noted complications were recorded. When applicable, elapsed time between recurrent interventions was recorded. Results: Medical records were available for a total of nine patients who underwent aspiration and injection of 34 cysts. Five of the nine patients required therapy for additional cyst formation an average of 11.8 months after initial intervention. There have been no known instances of facial nerve or parotid gland injury, and the only recorded postprocedure complaints were pain and mild edema. Conclusions: While multiple cysts may arise and serial intervention may be required, we believe that in association with broader clinical experience, the data presented here support aspiration and sodium morrhuate injection as a safe, minimally invasive, and efficacious technique in the treatment of benign lymphoepithelial cysts of the parotid gland in the HIV-positive population.

KW - HIV

KW - Lymphoepithelial cyst

KW - Parotid gland

KW - Sclerotherapy

KW - Sodium morrhuate

UR - http://www.scopus.com/inward/record.url?scp=66349131011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349131011&partnerID=8YFLogxK

U2 - 10.1002/lary.20205

DO - 10.1002/lary.20205

M3 - Article

C2 - 19358192

AN - SCOPUS:66349131011

VL - 119

SP - 868

EP - 870

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 5

ER -